Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses ; volume:22 ; number:1 ; day:31 ; month:5 ; year:2024 ; pages:1-16 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (31.5.2024), 1-16, 12.2024
- Creator
-
Larkin, Riley M.
Lopez, Diana C.
Robbins, Yvette L.
Lassoued, Wiem
Canubas, Kenneth
Warner, Andrew
Karim, Baktiar
Vulikh, Ksenia
Hodge, James W.
Floudas, Charalampos S.
Gulley, James L.
Gallia, Gary L.
Allen, Clint T.
London, Nyall R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-024-05339-9
- URN
-
urn:nbn:de:101:1-2408082117372.225693369374
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
2025-08-14T10:54:55+0200
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Larkin, Riley M.
- Lopez, Diana C.
- Robbins, Yvette L.
- Lassoued, Wiem
- Canubas, Kenneth
- Warner, Andrew
- Karim, Baktiar
- Vulikh, Ksenia
- Hodge, James W.
- Floudas, Charalampos S.
- Gulley, James L.
- Gallia, Gary L.
- Allen, Clint T.
- London, Nyall R.
- SpringerLink (Online service)
Other Objects (12)
Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
Ectopic Cushing’s syndrome secondary to olfactory neuroblastoma
Tumor-intrinsic IFNα and CXCL10 are critical for immunotherapeutic efficacy by recruiting and activating T lymphocytes in tumor microenvironment
![New diagnostic and potential predictive factors in olfactory neuroblastoma, [...]. [Band]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
New diagnostic and potential predictive factors in olfactory neuroblastoma, [...]. [Band]
Mixed Olfactory Neuroblastoma and Adenocarcinoma with In Situ Neuroendocrine Hyperplasia
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma
Generation and analysis of anti-ganglioside antibodies for the immunotherapeutic treatment of high-risk neuroblastoma
Endoscopy-assisted medial canthus incision for olfactory neuroblastoma: a case report
Gamma Knife® radiosurgery for recurrent intracranial olfactory neuroblastoma (esthesioneuroblastoma): a case report
Esthesioneuroblastoma (Olfactory Neuroblastoma): Overview and Extent of Surgical Approach and Skull Base Resection
Experiences and Outcomes in Olfactory Neuroblastoma Over A Decade at a Tertiary Cancer Center
Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
Ectopic Cushing’s syndrome secondary to olfactory neuroblastoma
Tumor-intrinsic IFNα and CXCL10 are critical for immunotherapeutic efficacy by recruiting and activating T lymphocytes in tumor microenvironment
New diagnostic and potential predictive factors in olfactory neuroblastoma, [...]. [Band]
Mixed Olfactory Neuroblastoma and Adenocarcinoma with In Situ Neuroendocrine Hyperplasia
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma
Generation and analysis of anti-ganglioside antibodies for the immunotherapeutic treatment of high-risk neuroblastoma
Endoscopy-assisted medial canthus incision for olfactory neuroblastoma: a case report
Gamma Knife® radiosurgery for recurrent intracranial olfactory neuroblastoma (esthesioneuroblastoma): a case report
Esthesioneuroblastoma (Olfactory Neuroblastoma): Overview and Extent of Surgical Approach and Skull Base Resection
Experiences and Outcomes in Olfactory Neuroblastoma Over A Decade at a Tertiary Cancer Center
Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
Ectopic Cushing’s syndrome secondary to olfactory neuroblastoma
Tumor-intrinsic IFNα and CXCL10 are critical for immunotherapeutic efficacy by recruiting and activating T lymphocytes in tumor microenvironment
New diagnostic and potential predictive factors in olfactory neuroblastoma, [...]. [Band]
Mixed Olfactory Neuroblastoma and Adenocarcinoma with In Situ Neuroendocrine Hyperplasia
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma
Generation and analysis of anti-ganglioside antibodies for the immunotherapeutic treatment of high-risk neuroblastoma
Endoscopy-assisted medial canthus incision for olfactory neuroblastoma: a case report
Gamma Knife® radiosurgery for recurrent intracranial olfactory neuroblastoma (esthesioneuroblastoma): a case report
Esthesioneuroblastoma (Olfactory Neuroblastoma): Overview and Extent of Surgical Approach and Skull Base Resection